Nervonik

About Nervonik

Nervonik is a California-based medical technology company focused on developing the smallest, most advanced, and power-efficient neuromodulation implants to provide non-narcotic treatment options for chronic neuropathic pain. Their mission is to offer effective solutions that improve quality of life by targeting the peripheral nervous system.

Products & Services

Neuromodulation PNS Implants:Tiny, power-efficient implants targeting the peripheral nervous system to manage chronic neuropathic pain. Features include wireless power transfer, minimally invasive procedures, and digital app controls. Currently available for research purposes pending FDA approval.

Specialties

Neuromodulation Technology Chronic Neuropathic Pain Treatment Peripheral Nervous System Targeting Neural-Sensing Integrated Circuits

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Series A T: - FT: Series A	A: 13000000 MR: - FA: $13 million FAN: 13000000	D: 2025-03-04 FD: 2025-03-04	3 investors

Series A Latest

2025-03-04

$13.0M

3 investors (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

A

Aydin Babakhani

CEO, Founder, and Board Member

T

Timothy Deer, MD

Chief Clinical Advisor

T

Tim Corvi

Chief Operating Officer

J

Jeff Kramer, PhD

Chief Scientific Officer

A

Andrew Filler, JD

General Counsel

D

David Sarisky, JD

Patent Counsel

View 12 more team members with Pro

Unlock Full Team Directory

Recent News

Nervonik Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised